ARS Pharmaceuticals Eulerpool vesti

ARS Pharmaceuticals Eulerpool News

ARS Pharmaceuticals Akcija Vesti

ARS Pharmaceuticals праћен је од стране многих новинара и инвеститора широм света. Најсвежије ARS Pharmaceuticals вести окупљамо овде.

• 28. мај ·

  Yahoo
  Top US Growth Companies With High Insider Ownership To Watch In May 2024
• 14. мај ·

  TipRanks
  Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)
• 13. мај ·

  Yahoo
  ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...
• 11. мај ·

  Yahoo
  ARS Pharmaceuticals First Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.16 loss in 1Q 2023)
• 10. мај ·

  TipRanks
  ARS Pharmaceuticals Unveils Updated Corporate Presentation
• 9. мај ·

  Yahoo
  ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
• 9. мај ·

  InvestorPlace
  SPRY Stock Earnings: ARS Pharmaceuticals Meets EPS for Q1 2024
• 9. мај ·

  Seeking Alpha
  ARS Pharmaceuticals GAAP EPS of -$0.11
• 30. април ·

  Yahoo
  ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization Application to EMA’s CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand
• 30. април ·

  Thefly.com
  ARS Pharmaceuticals submits response for neffy MA, partners with CSL Seqirus